Stay updated on FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.

Latest updates to the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedAdded Cutaneous neuroendocrine carcinoma and Small cell lung carcinoma to the study's conditions list.SummaryDifference0.1%

- Check12 days agoChange DetectedHepatocellular carcinoma was added to the study's conditions list. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2. This is a minor site version update with no visible changes to study content.SummaryDifference0.0%

- Check48 days agoChange DetectedGastric cancer was added as a listed condition. The page revision updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.1%

- Check56 days agoChange DetectedRevision: v3.4.1 has been introduced, replacing the previous v3.4.0. This seems to be a system update with no changes to the study content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

Stay in the know with updates to FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT500±Checkpoint Inhibitors in Advanced Solid Tumors Clinical Trial page.